FDA Warns Hospira Again, This Time in India

Beleaguered Hospira has received an FDA warning letter following an inspection at the company’s India plant
June 5, 2013
Hospira has received another warning letter from the US FDA following an inspection at the company’s India plant in October 2012. Read the full story
Sign up for our eNewsletters
Get the latest news and updates

Related

Charles River reports lower Q4 2025 revenue in struggling CDMO business
UK pharmaceuticals exempt from tariffs in US drug pricing agreement
2026 Manufacturing Pharma Trends for Life Sciences
Sponsored
2026 AI Trends in Life Sciences
Sponsored